Physician profile
Michael Faloon
NPI 1043420136
$29,120.70
in general payments reported to CMS, 2019-2025
16 companies · $569 in 2025
The $569 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,242 · 2020: $11K · 2021: $1,867 · 2022: $10K · 2023: $1,508 · 2024: $703 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,779.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $22,165.78 | 2019-2025 | Tritanium, Cascadia Interbody System, Pyrenees Cervical Plate System |
| Medtronic USA, INC. | $1,701.36 | 2019-2020 | |
| Centinel Spine, LLC | $1,571.16 | 2019-2020 | |
| Nuvasive, INC. | $1,276.33 | 2019-2023 | Alif, Acp, Plif |
| Integrity Implants INC. | $797.50 | 2019-2022 | |
| Alphatec Spine, INC | $321.46 | 2024-2025 | Invictus Open, Solus Alif, Other - Miscellaneous |
| Depuy Synthes Sales INC. | $276.27 | 2019-2025 | Teligen |
| Royal Biologics, INC. | $218.33 | 2024-2025 | |
| Integrity Implants INC. Dba Accelus | $165.65 | 2024 | |
| Seaspine Orthopedics Corporation | $140.25 | 2022 | |
| Intrinsic Therapeutics | $115.65 | 2025 | Barricaid Acd (Annular Closure Device) |
| Choice Spine, LLC | $112.55 | 2024 | Triton, Thunderbolt Minimally Invasive Pedicle Screw Systems, Stratofuse |
| Medtronic, INC. | $105.01 | 2021 | |
| Carlsmed, INC. | $84.00 | 2022 | |
| Zimmer Biomet Holdings, INC. | $41.12 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $28.28 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Faloon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.